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Abstract: The biocompatibility of orthopaedic implants and their effects on fracture healing have key roles for success. In this study, it
was aimed to investigate the effects of a novel biocomposite consisting of hydroxyapatite (HA), hexagonal boron nitride (h-BN), chitosan
(Cs), and type 1 collagen (Ct1) on biocompatibility and fracture healing in rats. A total of 60 adult male Wistar rats weighing 300–500
g were used in the study. The rats were randomly divided into 2 groups named A (uncoated/control) and B (biocomposite coated).
Biocomposite (HA/h-BN/Cs/Ct1) coated and uncoated stainless-steel implants were used as intramedullary pins. Groups A and B were
divided into subgroups of A1 and B1 (15th day), A2 and B2 (30th day), A3 and B3 (45th day) according to the date of euthanasia. Clinical,
radiographic, haematological, biochemical, and histopathological findings were evaluated by pairwise comparisons. The findings were
consistent and similar. No statistically significant difference was found for a finding disturbing the biocompatibility. Histopathological
examinations showed that coating biomaterials did not resorb over the course of 15, 30, and 45 days. It is thus revealed that the content
is biocompatible. However, it has been concluded that it is necessary to increase the physical strength of the coating surface against
sterilization and surgical procedures. As a result, based on the interpretations of the clinical, radiographic, haematological, biochemical,
and histopathological findings, the biocompatibility of HA/h-BN/Cs/Ct1 biocomposite materials has been revealed.
Key words: Biomaterial, biocomposite, implant coating, boron nitride, electrophoretic deposition, experimental

1. Introduction
The success of orthopaedic implants may be affected by
various factors, but their biocompatibility and effects
on fracture healing have key roles. A number of events,
such as blood-implant surface interaction, inflammatory
processes, and primitive bone formation, are possible on
or between surfaces of tissue and implant [1,2]. In the past,
many coating biomaterials were used in order to improve
the properties of orthopaedic implants and overcome
unwanted features or results [2,3]. Many of them continue
to be discussed and investigated in various regards.
Implant surface properties have been examined in terms
of chemical composition, biocompatibility, roughness,
and such aspects, and coating design studies have been
done in order to develop ideal implants [2,4,5]. However,
optimizing the biological properties of coatings is still a
challenge. In this field, the in vivo results of products
developed by in vitro studies are important for new studies.
In this context, our research hypothesis has been the effects
of hydroxyapatite (HA)/hexagonal boron nitride (h-BN)/
chitosan (Cs)/type 1 collagen (Ct1) biocomposite on

biocompatibility and fracture healing which was designed
by Tozar in 2018 as a new implant coating biomaterial [6].
Each of these 4 different components was used alone or
in different combinations in a large number of in vitro or
in vivo studies [6–9]. In our study, we aimed to evaluate
the in vivo biocompatibility and fracture healing effects
of the newly designed biocomposite that contains these 4
components.
Hydroxyapatite (HA) has been used in a wide range of
orthopaedics and dental applications for decades due to its
high biocompatibility [10,11]. Due to its weak mechanical
properties, it is generally not suitable for use alone as a
biomaterial in applications that require resistance to load.
Thus, it is generally used as a coating material on metal
implant surfaces [12]. Due to its osteoconductive properties
and similarity to bone tissue, it has widespread use as a
coating material in order to increase the biocompatibility
and bioactivity properties of metal implants such as
stainless-steel, titanium (Ti), and alloys [7]. With advances
in materials science and nanotechnology, many studies
in which HA is combined with different strategies have
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been conducted. Thus, work is underway to produce new
materials with the desired characteristics [6,13].
Chitosan (Cs), as a biomaterial, has been studied
plentifully, especially in suture materials, dental-bone
implants, and artificial skin applications [14]. Adsorption
of biomaterials such as Cs is necessary to improve the
biological interfacial properties of prostheses, orthopaedic
devices, and tooth nests [15,16]. Among described
approaches for biomaterials, chitosan is a highly promising
option with its multifaceted and key roles [17,18].
In tissue engineering with type 1 collagen (Ct1), many
studies have been conducted on tissue scaffolds, bone
graft production, and wound healing improvement [19–
21]. It is often used on biomaterial surfaces to increase
cellular activities such as adhesion, proliferation, and
differentiation [22]. Despite the potential benefits in
stimulating new bone formation, there is insufficient
information about the effect of Ct1 coating [23].
Scientific studies on the use of hexagonal boron
nitride (h-BN) in biomedical products are progressing. A
theoretical study on the encapsulation of anticancer drugs
and an in vitro study on the production of biocomposite
revealed no toxic effects [24]. It has been reported as
biocompatible with muscle and neuroblastoma cells
[25]. It is found in many areas of usage, from industry
to cosmetics, but it is especially promising in medical
applications with its versatile material properties and
preventive properties of corrosion, oxidation, and
chemical reactions [26]. In vivo studies of biomaterials
containing h-BN are very limited. In particular, there is
no study on the in vivo results of the biocomposite in our
study. In this context, the biocomposite which constitutes

the working hypothesis will be the basis for further studies
to present new information with the in vivo results of its
biocompatibility and its effects on fracture healing as an
orthopaedic implant coating biomaterial [6,27].
2. Materials and methods
2.1. Fabrication and electrophoretic deposition of the
biocomposite material
Two different suspensions were prepared to contain
biopolymers and ceramic particles forming the
biocomposite material. Acetic acid (0.9 mL) was diluted
in 20 mL of water to prepare the first (biopolymer)
suspension. Cs (0.13 g) and Ct1 (0.0135 g) were completely
dissolved in this solution and exposed to ultrasonic
stirring for 5 min. For the second (ceramic) suspension,
0.4955 g of HA and 0.375 g of nano h-BN powder were
mixed into 30 mL of ethanol and also stirred similarly.
These 2 different suspensions were combined by ultrasonic
stirring for 30 min and then allowed to magnetically mix
for 24 h. With the final suspension stabilized at the end
of this period, the surface coating processes of stainlesssteel (Ø 1 mm) Kirschner (K) wires were performed at an
electrophoretic deposition (EPD) mixing speed of 250 rpm
with the electrophoretic deposition potential of 16.10 V
and temperature of 34 °C [6]. After the coating process, the
implants were subjected to gas sterilization with ethylene
oxide and prepared for surgery by being packaged sterile
(Figure 1).
2.2. Animals and surgical procedure
The study approval was obtained from the Local Ethics
Board of Animal Experiments of Hatay Mustafa Kemal
University (protocol number 2015/6–12). All of the

Figure 1. Biocomposite coated stainless-steel K wire (A) and zoomed view (B). The implants are
sterilized with ethylene oxide gas sterilization and packaged (C).
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applications for the experiment were conducted in
accordance with the Turkish Code of the Welfare and
Protection of Animals Used for Experimental and Other
Scientific Purposes.
Sixty adult male Wistar Albino rats with an average
weight of 300–500 g purchased from the Experimental
Research and Application Center of Hatay Mustafa Kemal
University were used in the present study. All rats were
maintained in groups of 2 to 5 animals per cage on a 12
h light, 12 h dark circadian rhythm with water and food
provided ad libitum. One week prior to the study, the
animals were taken to the study place to undergo routine
health checks and time for adaptation was provided.
Experimental animals were randomly allocated to
2 groups (n = 30 per group), whereby Group A received
uncoated implants and Group B received biocomposite
coated implants. Each group was divided into 3 subgroups
(n = 10 per subgroup) according to the date of euthanasia.
Subgroups to be euthanized on the 15th day postoperatively
were A1 and B1, on the 30th day were A2 and B2, and on
the 45th day were A3 and B3.
Rats were anaesthetized by an intramuscular injection
(from the hindlimb, not operated) of xylazine (5 mg/kg)
and ketamine (50 mg/kg) combination. [28]. The animals
were prepared for surgery and positioned in lateral
recumbency. The skin incision was made parallel to the
femur. After the subcutaneous connective tissues, the
intermuscular septum (that separating m. biceps femoris
and m. gluteus superficialis) was incised and the femur was
reached as described [28]. In order to create the fracture
model, in this study, the femur was measured and the
level of the fracture was stated. A diaphyseal transversal

fracture was created by rigorous cutting movements with
a bone cutter. With the help of 2 small Halstead–Mosquito
haemostatic forceps, distal and proximal fragments of
fractures were held up and the reduction was achieved by
retrograde intramedullary pinning of uncoated (for Group
A) or biocomposite coated (for Group B) stainless-steel K
wires (Ø 1 mm) for osteosynthesis (Figure 2). The surgical
site was closed routinely with 2–0 poly (glycolide-colactide) sutures.
2.3. Postoperative procedure and clinical examination
Wound
care,
antibiotics
(ampicillin-sulbactam
combination, 250 mg/kg IM), and clinical examinations
were performed daily for 7 days postoperatively. General
findings such as habitus and food and water intake were
followed. Local findings on the incision site, gait, and
lameness were noted. Animals were weighed on the day of
surgery and on the 7th day postoperatively.
2.4. Haematological and biochemical examination
Blood samples were collected by intracardiac aspiration
during euthanasia. White blood cells (WBC),
lymphocytes, monocytes, granulocytes, red blood
cells (RBC), haemoglobin (HGB), haematocrit (HCT),
mean corpuscular volume (MCV), mean corpuscular
haemoglobin (MCH), mean cell haemoglobin
concentration (MCHC), red blood cell distribution width
(RDW), platelets (PLT), mean platelet volume (MPV),
platelet distribution width (PDW), and plateletcrit (PCT)
values were examined by complete blood count (Mindray
BC-2800Vet, Guangdong, China) and compared between
subgroups. Additionally, with the measurements of alkaline
phosphatase (ALP), aspartate aminotransferase (AST),
alanine aminotransferase (ALT), creatine kinase (CK),

Figure 2. Application of biocomposite coated implant with retrograde intramedullary technique.
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lactic acid dehydrogenase (LDH), total proteins (TP),
creatine (Cr), total calcium (total Ca), and phosphorus (P)
values, serum biochemistry profiles were examined (Gesan
Chem 200, Campobello di Mazara, Italy) and compared
between subgroups.
2.5. Radiographic evaluation
Radiographs were taken at 50 kV and 1 mAs (Intermedical,
Basic 100-30, Italy) in mediolateral and anteroposterior
positions. In the radiographic examination, callus
formation and fracture line were evaluated. For this
purpose, a radiographic union scale was adapted from
a previous study [29]. On this radiographic union scale,
the presence of callus formation and fracture line in the
anterior, posterior, medial, and lateral cortices was scored.
Each cortex was scored with 1 point if it still had a fracture
line with no callus, 2 points if the callus and fracture line
were both present, and 3 points if there was a callus with
no fracture line. Thus, the totals of the 4 cortices were
evaluated in the range of 4–12 points for each animal and
compared between subgroups.
2.6. Histopathological study
The femur bones were separated from the soft tissues and
calcified with nitric acid at a concentration of 3%. The
fragments from the calcified bones were fixed in a 10%
buffered formaldehyde solution. Tissues were subjected
to paraffinization after being routinely washed in water
and being passed through a series of graded alcohols and
xylols. Paraffin blocks were obtained by embedding the
tissue in paraffin. The sections were taken by a microtome
(Leica RM2235, Heidelberg, Germany) in 5 µm thickness
from these paraffin blocks and after drying in the oven, all
of them were stained with haematoxylin and eosin (H&E)
to be examined by binocular microscope (Olympus
BX50-F4, Tokyo, Japan) [30]. The histopathological
changes observed were scored as in previous studies by
Allen et al., Estai et al., and Naddaf et al. [31–33]. Lesions
such as bone (fracture) healing, inflammatory reactions,
connective tissue proliferation, cartilage formation, and
soft and hard callus formations were evaluated and scored
according to their severity.
The absence of inflammatory cells was evaluated as
0, a small number of inflammatory cell infiltration as
1, a moderate number of inflammatory cell infiltration
as 2, and infiltration of intense inflammatory cells as
3. Additionally, the scoring of the connective tissue
and cartilage formation was evaluated according to the
overall size of the callus. The scoring of soft and hard
callus formations was 1 when cartilage and fibrous tissue
increase was 10% or less, 2 if the increase was between
10% and 25%, and 3 if the increase was 25% or more. Bone
healing was determined according to the scoring system of
Allen’s fracture healing [31]. Accordingly, the scores were
considered as 0 in the presence of fibrous tissue alone, 1

for incomplete cartilage formation with fibrous tissue,
2 for cartilage formation, 3 for a slight trabecular bone
formation with a majority of cartilage formation, 4 for an
equal amount of cartilage and trabecular bone formations,
5 for a slight cartilage formation with a majority of
trabecular bone formation, and 6 for complete compact
bone ossification. Inflammatory changes were evaluated
according to their severity; in the absence of lesions or
cells it was scored as 0, mild lesions or small numbers of
cells were scored as 1, moderate lesions or intermediate
numbers of cells were scored as 2, and severe lesions or
numerous cells were scored as 3. Statistical analyses and
subgroup comparisons were made with these scores.
2.7. Statistical analysis
Statistical analysis of the study was done with the R 3.4.2.
package program. Descriptive statistics for the variants are
given with median and minimum–maximum values. The
conformity of continuous variants to normal distribution
was analysed by the Shapiro–Wilk test. The Mann–Whitney
U test was used for independent 2 group comparisons and
Kruskal–Wallis test was used for independent 3 group
comparisons. The Bonferroni corrected Mann–Whitney
U test was used for binary subgroup comparisons of
significant variants. In all the statistical comparisons,
comparisons with P-values below 0.05 were considered
statistically significant.
3. Results
3.1. Clinical evaluation
The first week and the following weeks after the surgery,
the general health of animals was good. The systemic
clinical findings of the animals such as general condition,
habitus, appetite, and feed and water consumption were
normal. In the examinations that continued until the time
of euthanasia, no systemic or local rejection complication,
or any complication that negatively affected the general
condition of the animals, was observed. In clinical
examinations, a limited number of local complications
such as wound dehiscence, pin migration, and
subcutaneous granulation tissue formation were recorded
similar for subgroups. There was no statistically significant
difference between the subgroups in terms of systemic or
local findings.
3.2. Radiographic evaluation
Statistical analyses of radiographic scores were performed
using the Mann–Whitney U test. Median, minimum–
maximum, and P-values of radiographic scores of
all subgroups are presented (Table 1). There was no
statistically significant difference between the subgroups.
No significant adverse effects were observed in Group
B that adversely affected biocompatibility or fracture
healing. Radiographic images from subgroups are shown
in Figure 3.
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Table 1. Median, minimum–maximum, and P-values of radiographic scores
of all subgroups.
Subgroups

A1

B1

A2

B2

A3

B3

Score
(min–max)

9
(8–10)

8.5
(8–10)

8
(4–11)

8.5
(8–10)

9
(8–12)

10.5
(8–12)

P

0.853

0.247

0.280

Figure 3. Anteroposterior (AP) and mediolateral (ML) radiographic samples from subgroups. (a) and (b) views are from A1, (c) and
(d) views are from B1 subgroups (15 days). It shows that fixation persists with external callus onset in both A1 and B1. (e) and (f) views
are from A2, (g) and (h) views are from B2 subgroups (30 days). It shows that fixation persists with callus formation in both A2 and
B2. (i) and (j) views are from A3, (k) and (l) views are from B3 subgroups (45 days). It shows that fixation persists, callus formation has
progressed, and the transition to the remodelling stage has begun in both A3 and B3. Radiographic results were similar for subgroups
of the same days and no significant difference was observed for the evidence of impaired biocompatibility.

3.3. Haematological and biochemical results
Complete blood count results were evaluated by pairwise
comparison of subgroups. Lymphocyte values were
significantly higher in the A1 subgroup (P = 0.043) in
comparison to subgroups A1–B1. In comparison of
subgroups A2–B2, the MCV and MCH values were
significantly higher in the B2 subgroup (P = 0.003 and P
< 0.001, respectively). In comparison of subgroups A3–
B3, the RDW values were significantly higher in the B3
subgroup (P = 0.002).
The results of serum biochemistry profiles were also
evaluated by pairwise comparison of subgroups. In group

80

A1, Cr was found to be significantly higher than in the B1
subgroup (P = 0.003). In subgroup A2, the ALP value was
found to be significantly lower (P < 0.001) compared to
subgroup B2, and additionally CK, LDH, Cr, and BUN
values were significantly higher than in subgroup B2 (P =
0.007, P = 0.002, P = 0.019, and P < 0.001). When the A3–
B3 subgroups were compared, none had any statistically
significant difference.
3.4. Histopathological results
The removed femoral bones of 60 rats were examined
microscopically. The obtained histopathological findings
were scored according to their degree in terms of bone
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healing, inflammatory reaction, connective tissue
proliferation, cartilage formation, and soft and hard callus
formations (Table 2; Figures 4–6). The data were analysed
statistically by Mann–Whitney U and Kruskal–Wallis
tests.
When the histopathological examinations were
evaluated, mononuclear cell infiltration, fibroblastic
proliferation, and the new granulation tissue formation
mixed with collagen accumulation were similar around
the fracture site in all subgroups (A1, B1, A2, B2, A3, and
B3). In all subgroups, a small number of erythrocytes
scattered across the connective tissue were seen at the
ends of the fracture and just below the periosteum. In all
subgroups of group B (B1, B2, and B3), dark brownishblack pigment accumulations were observed in the newly
formed granulation tissue, especially in the medullary
canal, between the bone tips, around the vessels, in
macrophages, and in the osteoid tissue (Figure 7).
The abundance of hyaline cartilage formations,
showing the early stage of endochondral ossification with
a small amount of osteoid accumulation, was similar in
both A and B groups. In Groups A and B, hypertrophic
chondrocytes and hyaline cartilage formation between the
ends of the bone were marked and intense. When the soft
callus was evaluated, no statistically significant difference
was found between the subgroups.
Osteoid mineralization and trabecular and lamellar
bone tissue formations replacing soft callus in the late
phase of bone healing did not show statistically significant
difference between Groups A and B. The presence of diffuse
hypertrophic chondrocytes in the osteoid mineralization
tissue in new bone formations (hard callus) was not also
statistically significant. Lamellar bone formation with
hypertrophic chondrocytes in new bone tissue formation
was prominent in both Group A and Group B.
By pairwise comparison of histopathological results
and scores of subgroups, no significant differences were

found in bone healing, inflammatory reaction, connective
tissue proliferation, cartilage, or soft callus and hard callus
formations.
4. Discussion
Bone healing is a process that may be affected by various
factors. Properties of the used biomaterials are crucial in
this process and their biocompatibility is essential. In this
context, in order to detect any possible negative effect on
the fracture healing caused by inadequate biocompatibility
of coating biomaterial, it was essential to see the results
in vivo. In our study, the results clearly showed that the
new biocomposite coating biomaterial is biocompatible
and had no adverse effects on the fracture healing
compared to the uncoated implant group. Thus, the results
were consistent with previous studies and the proposed
hypothesis [2,8,9,16,34–36].
HA/h-BN/Cs/Ct1 biocomposite coating designed by
Tozar et al. was applied to the stainless-steel K wires by
electrophoretic deposition [6,13]. Since it was the first in
vivo study, stainless-steel K wire was preferred. Therefore,
the intramedullary pin method was preferred for fixation
of the experimental fracture. K wire and intramedullary
pin methods have been used in many studies on fracture
healing due to their application advantages [32,37].
Ethylene oxide was found to be suitable for sterilization
of biocomposite coated K wires. It was determined that
the heat sterilization methods were not suitable because
of leading to peeling or the carbonization of the coating
material. Therefore, studies are needed to increase
physical resistance to the sterilization processes. The
surfaces of biocomposite coated implants were found
to be possibly damaged by the effect of implant-bone
frictions during fracture fixation manipulations. Although
it was biocompatible, it was determined that the physical
strength of the coating biomaterial should be improved.
With the improvement of the mechanical properties of

Table 2. Median, minimum–maximum scores, and P-values of histopathological results.
Bone healing

Inflammatory
reaction

Connective tissue
proliferation

Cartilage
formation

Soft callus
formation

Hard callus
formation

A1

0.50 (0–1)

1 (1–2)

3 (1–3)

1.5 (1–3)

2.5 (1–3)

1 (0–2)

B1

1 (0–3)

1 (1–3)

3 (2–3)

1 (0–3)

3 (1–3)

1 (0–2)

P

0.481

0.393

0.971

0.631

0.631

0.796

A2

2 (0–4)

2 (1–3)

3 (1–3)

2.5 (1–3)

2 (1–3)

1.5 (1–3)

B2

2 (0–4)

2 (1–3)

3 (1–3)

2 (1–3)

2.5 (2–3)

1.5 (1–2)

P

0.684

0.579

0.912

0.853

0.579

0.853

A3

5 (3–5)

1 (0–2)

1 (1–3)

2.5 (1–3)

1 (1–3)

3 (2–3)

B3

5 (3–5)

1 (0–2)

2 (1–3)

2.5 (1–3)

2 (1–3)

2.5 (1–3)

P

1.000

0.315

0.579

0.853

0.143

0.739
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Figure 4. Score comparison of histopathological results of A1 and B1 subgroups.

Figure 5. Score comparison of histopathological results of A2 and B2 subgroups.

the biocomposite coating, it is thought that further studies
can be planned by coating other sorts of implants such as
plates, screws, or prostheses. Also in further studies, more
detailed monitoring of the fracture healing with micro-CT
imaging devices is recommended [38].
When systemic complications such as foreign-body
reaction, chronic inflammatory response, infection,
septicaemia, toxicity, and allergic or hypersensitivity
reactions are caused by implant coating biomaterial, it is
likely to see one or more general clinical findings such as
hyperthermia/hypothermia, respiratory or pulse increase,
loss of appetite, cachexia, or dehydration [39,40]. In our
study, no statistically significant difference was observed
between Groups A and B in terms of these systemic clinical
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findings. Local findings were also similar. Therefore, the
similarity of general and local clinical findings indicates
that the coating biomaterial is biocompatible.
In haematological evaluation, since there were no
significant differences in other values, in spite of differences
in MCV, MCH, and RDW, no reaction disrupting
biocompatibility was observed. Biocomposite coated
implants also do not have any negative effect on blood
values. Based on this information, it is considered that the
biocomposite coating is biocompatible [39,41]. From the
blood serum biochemistry evaluation, it can be concluded
that the Cr value was significantly higher in subgroup A1
compared to subgroup B1, and that postoperative muscle
tissue healing was better in subgroup B1 since the Cr level

DEVECİ et al. / Turk J Vet Anim Sci

Figure 6. Score comparison of histopathological results of A3 and B3 subgroups.

Figure 7. Soft callus in a section belonging to subgroup A1 (a): fibroblasts (thin arrows), hyaline cartilage, and chondrocytes (arrowhead).
Bone end in a section of subgroup A2 (b): hyaline cartilage and hypertrophic chondrocytes (HK). In a section of A3 subgroup (c):
hypertrophic chondrocytes (HK) and lamellar bone formations (L). In a section of B1 subgroup (d): medullary channel, pigment
accumulations between the bone ends and in the granulation tissue (blue arrows). In a section of B2 subgroup (e): collagen deposition
between the bone ends, erythrocyte deposits (thick arrow), black-coloured pigment deposits (thin arrows) around the veins in the newly
formed granulation tissue and the connective tissue. Hard callus formation in a section from B3 subgroup (f): osteoid mineralization
(star), hyaline cartilage (HK), and lamellar bone (L), newly formed bone formations (arrow).

is also an indicator for muscle tissue catabolic events [42].
The ALP and ALT values in subgroup B2 were higher than
in subgroup A2, indicating that the mineralization and
calcification might be increased in the period involving
the callus formation since it is stated that ALP and ALT

enzymes are high in cases where mineralization and
calcification events increase [43,44]. In subgroup B2, CK,
LDH, Cr, and BUN values were significantly lower than
in subgroup A2, which may indicate that muscle tissue
healing is better in subgroup of B2, or that cellular damage
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is less in subgroup B2 [42,43]. No significant differences
were found in biochemical findings of subgroups A3 and
B3. Thus, the biocomposite coating did not cause any effect
that disrupted the biochemistry profile on day 45. Based
on these findings, it was concluded that the biochemistry
profile was consistent with the biocompatibility in all the
periods of 15, 30, and 45 days. In addition, the differences
in the B2–A2 comparison indicate the favourable effects
especially at the time of callus formation.
The absence of a statistically significant difference
in the radiographic findings of the A and B groups also
showed that the biocomposite coating had no negative
effect on the fracture healing and did not cause any
biocompatibility disruptive effect. However, there is no
evidence that it improves fracture healing.
Histopathological scores were compared pairwise with
the subgroups showing the same fracture healing period;
results were similar in terms of fracture healing, cartilage
formation, inflammatory reactions, connective tissue
proliferation, and soft and hard callus formations, and were
consistent with other findings. Thus, the biocompatibility
of biocomposite coated implants during fracture healing
was determined and supported by the histopathological
examination. However, based on these results, it cannot be
said that it significantly increases or accelerates the fracture
healing. It was determined histopathologically that the
desired results were obtained in terms of biocompatibility
in all 3 periods, but there was no additional superiority such
as improving the fracture healing. The presence of dark
brownish-black pigmentation points in histopathological
examination, especially in the medullary canal and in
some of the stated areas in subgroups B1, B2, and B3, is an
indication that the coating biomaterial is not resorbed on
the 15th, 30th, and 45th days.
In the comparison of the subgroups that belonged
to Groups A and B (A1-A2-A3 and B1-B2-B3), the
clinical, radiographic, haematological, biochemical, and
histopathological findings are found to be consistent
with the fracture healing time course. This consistent
course is indicative of the biocompatibility of the
biocomposite coated group during the fracture healing.
In addition, to elaborate on the evaluation in further
studies, supplementary methods are recommended such
as immunohistochemistry or biomarkers [33].
There are numerous studies in which HA, h-BN, Cs,
and Ct1 are used in biocomposites as double or triple
components [8,14,22,26,36,45–52]. However, the in vivo
results of a biocomposite with these 4 components were
investigated in our study for the first time. It is thought
by many researchers that HA/Cs composites are suitable
for bone regeneration and repair in orthopaedic surgery
thanks to their superior properties [51,53]. For example,
in one study, a hybrid gel was produced by distributing
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nano-HA particles into Cs hydrogels in order to increase
the mechanical and bone compatibility characteristics and
it was reported to have potential for use as an injectable
bone scaffold [54]. Many articles on the production
of similar HA/Cs hybrids or composite materials for
orthopaedic use can be found in the literature [55–57]. In
one study, HA/Ct1/poly (1-lactic acid) biocomposites were
coated by the method of spin coating on the magnesium
alloy of AZ31 and the bonds of HA/Ct1 macromolecules
were suggested to resemble the natural bone [45]. In
another study, the Ct1/HA biocomposites were coated
on orthopaedic Ti implants by the plasma spray method
and it was suggested that the Ct1 infiltrated porous HA
coatings were very superior materials that allowed cell
attachment, proliferation, and transformation, and that
may be useful [34]. In one study, a team claimed that
they obtained HA/Ct1 nanocomposites for the first time
by electrodeposition in a thick nanoporous structure that
had high biocompatibility with in vitro osteoblast culture
experiments [46]. In a study in which electrochemical
mineralization of HA was examined on Ti substrates
together with Ct1 and Cs, it was stated that tighter
mineralization was formed than with pure HA coatings;
thus, biocompatibility and cell proliferation were more
effective [58]. Our study also clearly demonstrates that the
in vivo results are consistent with previous studies, and
the biocompatibility of biocomposite coating containing
HA/h-BN/Cs/Ct1.
In order to improve the mechanical properties of
biomaterials and increase their biocompatibility, h-BN has
been used in many studies as a biocomposite component
[8,9,36,48–50,59,60]. For example, in one study, it was
demonstrated that some particular mechanical properties
of HA were improved with the addition of boron nitride
nanotubes, and it was reported that there was no negative
effect on the viability and proliferation of osteoblast cells
[9]. In another study, boron nitride nanotubes composed
of h-BNs were reported to be good candidates for the
development of the properties of polymers, biocomposites,
and tissue scaffolds due to their low toxicity, high
mechanical strength, and chemical stability properties
[49]. It was reported that boron nitride is biocompatible
in a study where it was used in combination with gelatine
and the denaturing form of collagen [60]. Also, HA/hBN was applied by Atila et al. to experimental femoral
defects and there was no increase in serum boron levels.
Therefore, it was stated as promising [50]. Göncü et al.
reported that they successfully applied h-BN/HA coating
to Ti implants. They stated that they expected this coating
to support cell proliferation and have high bioactivity
[48]. However, in another study, Cs/h-BN and Cs/h-BN/
TiO2 biocomposite coatings were applied to stainless-steel
(316L) implants by EPD and it was stated that they may
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be used to give antibacterial properties but not bioactivity
[8]. According to the results of our study, although
the biocomposite coating material including the h-BN
component is biocompatible, it cannot be said that any
increase is demonstrated in bioactivity. When the studies
are evaluated, it is seen that the in vivo research results of
the biocomposites containing the h-BN component are
limited compared to HA, Cs, and Ct1 components. In
this respect, it is of particular importance that the h-BN
component is present in the biocomposite coating used in
our study.
In light of the data revealed above by a large number of
researchers and the results of our study, the biocomposite
coating with HA/h-BN/Cs/Ct1 content was found to be
biocompatible and nontoxic, consistent with previous
studies. In addition, it is seen that most studies are limited
to the investigation of the in vitro effects. In this respect, it
is considered that the in vivo results will provide scientific
contributions and a basis for further studies.
5. Conclusions
This study has shown that the biocomposite coating material
with the content of HA/h-BN/Cs/Ct1 was biocompatible in
an in vivo experimental rat model and did not cause any
negative effects to disrupt the fracture healing. However,
there was no significant increase in the fracture healing or
acceleration. Especially in the period of callus formation,
which is important in the fracture healing, biochemical
results are noteworthy considering their positive effects.
It was determined histopathologically that the coating
biomaterial was not resorbed at the 15th, 30th, and 45th

days. In addition, some physical disadvantages resulting
from the coating method were determined. Further studies
are needed to develop the biocomposite coating and obtain
more detailed results. In new studies, it may be aimed to
increase the fracture healing by changing the concentration
and/or amounts of the biomaterial components used in the
coating, or by changing the coating method. Studies intended
to increase osteointegration for different implants such as
screws or prostheses can be designed. With this purpose,
further studies are recommended with biomechanical tests
and micro-CT which allow for more detailed monitoring
of the fracture healing. Immunohistochemistry, biomarker,
or toxicological examinations are also recommended.
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